These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Evidence that the soluble factors secreted by activated immune cells suppress replication of human neurotropic JC virus DNA in glial cells. Chang CF; Otte J; Kerr DA; Välkkilä M; Calkins CE; Khalili K Virology; 1996 Jul; 221(1):226-31. PubMed ID: 8661431 [TBL] [Abstract][Full Text] [Related]
9. Natalizumab has no direct biological effect on JC virus infectivity in permissive human neural cell lines. Suzuki T; Yamanouchi S; Sunden Y; Orba Y; Kimura T; Sawa H J Med Virol; 2010 Jul; 82(7):1229-35. PubMed ID: 20513089 [TBL] [Abstract][Full Text] [Related]
10. DNA-sequence rearrangement required for the adaptation of JC polyomavirus to growth in a human neuroblastoma cell line (IMR-32). Yogo Y; Hara K; Guo J; Taguchi F; Nagashima K; Akatani K; Ikegami N Virology; 1993 Dec; 197(2):793-5. PubMed ID: 8249302 [TBL] [Abstract][Full Text] [Related]
11. Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells. Nukuzuma S; Nakamichi K; Kameoka M; Sugiura S; Nukuzuma C; Tasaki T; Takegami T Microbiol Immunol; 2016 Apr; 60(4):253-60. PubMed ID: 26935240 [TBL] [Abstract][Full Text] [Related]
12. Molecular biology and immunoregulation of human neurotropic JC virus in CNS. Sweet TM; Del Valle L; Khalili K J Cell Physiol; 2002 Jun; 191(3):249-56. PubMed ID: 12012320 [TBL] [Abstract][Full Text] [Related]
13. Propagation of the human polyomavirus, JCV, in human neuroblastoma cell lines. Shinohara T; Nagashima K; Major EO Virology; 1997 Feb; 228(2):269-77. PubMed ID: 9123834 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. Kerr DA; Chang CF; Gordon J; Bjornsti MA; Khalili K Virology; 1993 Oct; 196(2):612-8. PubMed ID: 8396804 [TBL] [Abstract][Full Text] [Related]
15. Role of N-linked glycosylation of the 5-HT2A receptor in JC virus infection. Maginnis MS; Haley SA; Gee GV; Atwood WJ J Virol; 2010 Oct; 84(19):9677-84. PubMed ID: 20660194 [TBL] [Abstract][Full Text] [Related]
16. Interferon beta1-a and selective anti-5HT(2a) receptor antagonists inhibit infection of human glial cells by JC virus. O'Hara BA; Atwood WJ Virus Res; 2008 Mar; 132(1-2):97-103. PubMed ID: 18093678 [TBL] [Abstract][Full Text] [Related]
17. Suppressive effect of PARP-1 inhibitor on JC virus replication in vitro. Nukuzuma S; Kameoka M; Sugiura S; Nakamichi K; Nukuzuma C; Takegami T J Med Virol; 2013 Jan; 85(1):132-7. PubMed ID: 23074024 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the transcriptional control region of JC polyomavirus in cerebrospinal fluid from HIV-negative patients with progressive multifocal leucoencephalopathy. Fedele CG; Polo C; Tenorio A; Niubò J; Ciardi MR; Pérez JL J Med Virol; 2006 Oct; 78(10):1271-5. PubMed ID: 16927288 [TBL] [Abstract][Full Text] [Related]
19. An siRNA against JC virus (JCV) agnoprotein inhibits JCV infection in JCV-producing cells inoculated in nude mice. Matoba T; Orba Y; Suzuki T; Makino Y; Shichinohe H; Kuroda S; Ochiya T; Itoh H; Tanaka S; Nagashima K; Sawa H Neuropathology; 2008 Jun; 28(3):286-94. PubMed ID: 18179406 [TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a carrier cell culture producing high titres of polyoma JC virus. Nukuzuma S; Yogo Y; Guo J; Nukuzuma C; Itoh S; Shinohara T; Nagashima K J Med Virol; 1995 Dec; 47(4):370-7. PubMed ID: 8636705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]